+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anavex Life Sciences Corp - logo

Anavex Life Sciences is a biopharmaceutical company that develops differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat diseases of the central nervous system, pain and various types of cancer. The company's best known product is ANAVEXTM 2-73, a compound being developed to treat Alzheimer's disease, Parkinson's disease and related diseases. The company was founded in 2006 and is based in New York.

Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Muscarinic Acetylcholine Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • September 2023
  • 81 Pages
  • Global
From
Rett Syndrome Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Rett Syndrome Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 89 Pages
  • Global
From
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 580 Pages
  • Global
From
Rett Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Rett Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 178 Pages
  • Global
From
Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 868 Pages
  • Global
From
Parkinson's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Parkinson's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 1308 Pages
  • Global
From
Fragile X Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 194 Pages
  • Global
From
Epilepsy - Pipeline Review, H2 2020 - Product Thumbnail Image

Epilepsy - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 662 Pages
  • Global
From
Dementia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dementia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 537 Pages
  • Global
From
Multiple Sclerosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1114 Pages
  • Global
From
Interferon - Global Strategic Business Report - Product Thumbnail Image

Interferon - Global Strategic Business Report

  • Report
  • May 2024
  • 78 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Visceral Pain - Pipeline Review, H2 2018 - Product Thumbnail Image

Visceral Pain - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 113 Pages
  • Global
From
Anavex Life Sciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Anavex Life Sciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Comprehensive Report on Anavex Life Sciences Corp, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Anavex Life Sciences Corp, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Anavex Life Sciences Corp (AVXL) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • December 2023
  • 45 Pages
From
Loading Indicator